John Gillespi, MD
Plastic Surgery · Wilmington, DENPI 1790002954
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,237 of the $4,797 with a category attached, or 67.5%. 19 manufacturers reported payments, led by Musculoskeletal Transplant Foundation Inc. at 49.3% of the total. Reporting peaked in 2021 at $1,550 and has fallen 94.7% since, to $82 in 2025.
Across 61 payments — averaging $78.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$2K
- Stryker$1K
- AbbVie$380
- KCI USA, Inc.$106
- Galderma Laboratories, L.p.$104
- Sientra, Inc.$82
- plus $430 from 13 others
What the payments were for
- Travel & lodging$3,23767%
- Food & beverage$1,56033%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 17 | $2,366 |
| Stryker | 5 | $1,330 |
| AbbVie(2 entities) | 9 | $380 |
| KCI USA, Inc. | 4 | $106 |
| Galderma Laboratories, L.p. | 4 | $104 |
| Sientra, Inc. | 1 | $82 |
| Mentor Worldwide LLC | 2 | $77 |
| Avita Medical Americas, LLC | 2 | $51 |
| TELA Bio, Inc. | 3 | $48 |
| Sanara Medtech Inc. | 3 | $43 |
| Baxter Healthcare | 2 | $41 |
| Integra Lifesciences Corporation | 2 | $33 |
| Polynovo North America LLC | 1 | $26 |
| Vertex | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Avanos Medical | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic surgery providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 41 | $1,599 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $275 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Wilmington
- John DanyoWilmington$2K
- Edward CatersonWilmington$976
- Joseph NapoliWilmington$581
- Mario AycartWilmington$85
- Lawrence ChangNewark$160K
- Katheryn WarrenNewark$1K
- Abdollah MalekNewark$608
- Joseph ThorntonNewark$363
- Patrick SwierLewes$243
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.